Direxion Daily TSLA Bull 1.5X Shares

ProShares UltraShort Bloomberg Natrl Gas

GraniteShares 1.5x Long NVDA Daily ETF

MicroSectors Gold Miners -3X Inverse Leveraged ETNs

GraniteShares 1.25x Long Tesla Daily ETF

ProShares UltraShort Silver

Direxion Daily S&P Biotech Bear 3X ETF

VS TR 2x Long VIX Futures ETF

Direxion Daily Gold Miners Bear 3X ETF

Direxion Daily FTSE China Bull 3X ETF

ProShares Ultra Bloomberg Natural Gas

T-REX 2X Inverse Tesla Daily Target ETF

Volatility Shares Trust 2x Ether ETF

MicroSectors Gold Miners 3X Leveraged ETN

ProShares Ultra Silver

Direxion Daily S&P Biotech Bull 3X ETF

United States Natural Gas

Direxion Daily Gold Miners Bull 3X ETF

ARK Genomic Revolution Multi-Sector ETF

iShares US Home Construction

Incannex Healthcare Limited American Depositary Shares

Innovative Eyewear Inc. Common Stock

Septerna Inc. Common Stock

HWH International Inc. Common Stock

DevvStream Corp. Common Stock

Rigetti Computing Inc. Common Stock

Super Micro Computer Inc. Common Stock

Oklo Inc.

EchoStar  Corporation Common Stock

EVgo Inc. Class A Common Stock

Inno Holdings Inc. Common Stock

Gryphon Digital Mining Inc Common Stock

Next Technology Holding Inc. Ordinary Shares

Kindly MD Inc. Common Stock

Nuvve Holding Corp. Common Stock

Oriental Rise Holdings Limited Ordinary Shares

Classover Holdings Inc. Class B Common Stock

MicroAlgo Inc. Ordinary Shares

Hyperscale Data Inc. Common Stock

JELD-WEN Holding Inc. Common Stock

Click here to get full coverage on Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock - Nasdaq

Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock  Nasdaq

Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock - Nasdaq

Click here to get full coverage on Analysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Estimates - Yahoo Finance

Analysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Estimates  Yahoo Finance

Analysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Estimates - Yahoo Finance

Click here to get full coverage on Breakeven Is Near for CorMedix Inc. (NASDAQ:CRMD) - simplywall.st

Breakeven Is Near for CorMedix Inc. (NASDAQ:CRMD)  simplywall.st

Breakeven Is Near for CorMedix Inc. (NASDAQ:CRMD) - simplywall.st

Click here to get full coverage on Cormedix (CRMD) Receives a Buy from RBC Capital - The Globe and Mail

Cormedix (CRMD) Receives a Buy from RBC Capital  The Globe and Mail

Cormedix (CRMD) Receives a Buy from RBC Capital - The Globe and Mail

Click here to get full coverage on CorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside Potential - Insider Monkey

CorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside Potential  Insider Monkey

CorMedix Inc. (CRMD): Among Billionaire Paul Singer’s Stock Picks with Huge Upside Potential - Insider Monkey

Click here to get full coverage on CorMedix Q1 2025 Financial Results: How to Access the Latest Earnings Call May 6 - Stock Titan

CorMedix Q1 2025 Financial Results: How to Access the Latest Earnings Call May 6  Stock Titan

CorMedix Q1 2025 Financial Results: How to Access the Latest Earnings Call May 6 - Stock Titan

Click here to get full coverage on The Hidden Risks Behind CorMedix's First Profitable Quarter (NASDAQ:CRMD) - Seeking Alpha

The Hidden Risks Behind CorMedix's First Profitable Quarter (NASDAQ:CRMD)  Seeking Alpha

The Hidden Risks Behind CorMedix's First Profitable Quarter (NASDAQ:CRMD) - Seeking Alpha

Click here to get full coverage on (CRMD) Investment Analysis - news.stocktradersdaily.com

(CRMD) Investment Analysis  news.stocktradersdaily.com

(CRMD) Investment Analysis - news.stocktradersdaily.com

Click here to get full coverage on CorMedix Hits Major Milestone: Reports First Ever Profitable Quarter with $39.1M Revenue, Raises Guidance - Stock Titan

CorMedix Hits Major Milestone: Reports First Ever Profitable Quarter with $39.1M Revenue, Raises Guidance  Stock Titan

CorMedix Hits Major Milestone: Reports First Ever Profitable Quarter with $39.1M Revenue, Raises Guidance - Stock Titan

Click here to get full coverage on $CRMD stock is up 15% today. Here's what we see in our data. - Nasdaq

$CRMD stock is up 15% today. Here's what we see in our data.  Nasdaq

$CRMD stock is up 15% today. Here's what we see in our data. - Nasdaq

Click here to get full coverage on CorMedix Inc.'s (NASDAQ:CRMD) 35% loss last week hit both individual investors who own 56% as well as institutions - simplywall.st

CorMedix Inc.'s (NASDAQ:CRMD) 35% loss last week hit both individual investors who own 56% as well as institutions  simplywall.st

CorMedix Inc.'s (NASDAQ:CRMD) 35% loss last week hit both individual investors who own 56% as well as institutions - simplywall.st

Click here to get full coverage on CorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call Transcript - Insider Monkey

CorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call Transcript  Insider Monkey

CorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call Transcript - Insider Monkey

Click here to get full coverage on CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates  Yahoo Finance

CorMedix (CRMD) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance

Click here to get full coverage on CorMedix Hits Major Milestone: First-Ever Profitable Quarter Signals Strong Growth Ahead - Stock Titan

CorMedix Hits Major Milestone: First-Ever Profitable Quarter Signals Strong Growth Ahead  Stock Titan

CorMedix Hits Major Milestone: First-Ever Profitable Quarter Signals Strong Growth Ahead - Stock Titan

Click here to get full coverage on We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely - Yahoo Finance

We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely  Yahoo Finance

We're Hopeful That CorMedix (NASDAQ:CRMD) Will Use Its Cash Wisely - Yahoo Finance

Click here to get full coverage on CorMedix CEO Sets Stage for Strategic Updates at Elite Needham Healthcare Conference - Stock Titan

CorMedix CEO Sets Stage for Strategic Updates at Elite Needham Healthcare Conference  Stock Titan

CorMedix CEO Sets Stage for Strategic Updates at Elite Needham Healthcare Conference - Stock Titan

Click here to get full coverage on Investors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five years - Yahoo Finance

Investors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five years  Yahoo Finance

Investors in CorMedix (NASDAQ:CRMD) have seen decent returns of 81% over the past five years - Yahoo Finance

Click here to get full coverage on Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors - GlobeNewswire

Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors  GlobeNewswire

Kirby McInerney LLP Announces Investigation Against CorMedix Inc. (CRMD) on Behalf of Investors - GlobeNewswire

Click here to get full coverage on INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC - GlobeNewswire

INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC  GlobeNewswire

INVESTOR ALERT: Investigation of CorMedix Inc. (CRMD) Announced by Holzer & Holzer, LLC - GlobeNewswire

Click here to get full coverage on Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value - Yahoo Finance

Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value  Yahoo Finance

Institutions along with individual investors who hold considerable shares inCorMedix Inc. (NASDAQ:CRMD) come under pressure; lose 35% of holdings value - Yahoo Finance

Click here to get full coverage on CRMD Price Target Increased as Positive Momentum Builds | CRMD Stock News - GuruFocus

CRMD Price Target Increased as Positive Momentum Builds | CRMD Stock News  GuruFocus

CRMD Price Target Increased as Positive Momentum Builds | CRMD Stock News - GuruFocus

Click here to get full coverage on CorMedix (CRMD) Surges on Strong Q1 Earnings - GuruFocus

CorMedix (CRMD) Surges on Strong Q1 Earnings  GuruFocus

CorMedix (CRMD) Surges on Strong Q1 Earnings - GuruFocus

Click here to get full coverage on CorMedix: Q1 Earnings Snapshot - Norwalk Hour

CorMedix: Q1 Earnings Snapshot  Norwalk Hour

CorMedix: Q1 Earnings Snapshot - Norwalk Hour

Click here to get full coverage on Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts - simplywall.st

Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts  simplywall.st

Analysts Just Made A Massive Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Forecasts - simplywall.st

Click here to get full coverage on CRMD Stock Rating and Price Target Maintained by Analyst | CRMD - GuruFocus

CRMD Stock Rating and Price Target Maintained by Analyst | CRMD  GuruFocus

CRMD Stock Rating and Price Target Maintained by Analyst | CRMD - GuruFocus

Click here to get full coverage on CorMedix: A Fair-Priced Biotech Company With A Bright Future - Seeking Alpha

CorMedix: A Fair-Priced Biotech Company With A Bright Future  Seeking Alpha

CorMedix: A Fair-Priced Biotech Company With A Bright Future - Seeking Alpha

Click here to get full coverage on (CRMD) On The My Stocks Page - news.stocktradersdaily.com

(CRMD) On The My Stocks Page  news.stocktradersdaily.com

(CRMD) On The My Stocks Page - news.stocktradersdaily.com

Click here to get full coverage on CorMedix (CRMD) Surpasses Revenue and EPS Expectations in Q1 - GuruFocus

CorMedix (CRMD) Surpasses Revenue and EPS Expectations in Q1  GuruFocus

CorMedix (CRMD) Surpasses Revenue and EPS Expectations in Q1 - GuruFocus

Click here to get full coverage on CRMD Soars 19.40% as CorMedix Announces Preliminary Q1 Results and Raises H1 Guidance, But Will the Momentum Continue? - RagingBull

CRMD Soars 19.40% as CorMedix Announces Preliminary Q1 Results and Raises H1 Guidance, But Will the Momentum Continue?  RagingBull

CRMD Soars 19.40% as CorMedix Announces Preliminary Q1 Results and Raises H1 Guidance, But Will the Momentum Continue? - RagingBull

Click here to get full coverage on Cormedix Inc (CRMD) Q1 2025: Everything You Need To Know Ahead O - GuruFocus

Cormedix Inc (CRMD) Q1 2025: Everything You Need To Know Ahead O  GuruFocus

Cormedix Inc (CRMD) Q1 2025: Everything You Need To Know Ahead O - GuruFocus

Click here to get full coverage on Cormedix Inc (CRMD) Q1 2025 Earnings: EPS of $0.32 Beats Estimat - GuruFocus

Cormedix Inc (CRMD) Q1 2025 Earnings: EPS of $0.32 Beats Estimat  GuruFocus

Cormedix Inc (CRMD) Q1 2025 Earnings: EPS of $0.32 Beats Estimat - GuruFocus

Click here to get full coverage on (CRMD) Investment Report - news.stocktradersdaily.com

(CRMD) Investment Report  news.stocktradersdaily.com

(CRMD) Investment Report - news.stocktradersdaily.com

Click here to get full coverage on CorMedix: Finally In Commercialization Mode (NASDAQ:CRMD) - Seeking Alpha

CorMedix: Finally In Commercialization Mode (NASDAQ:CRMD)  Seeking Alpha

CorMedix: Finally In Commercialization Mode (NASDAQ:CRMD) - Seeking Alpha

Click here to get full coverage on Press Release Distribution & PR Platform - ACCESS Newswire

Press Release Distribution & PR Platform  ACCESS Newswire

Press Release Distribution & PR Platform - ACCESS Newswire

Click here to get full coverage on Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns - simplywall.st

Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns  simplywall.st

Here's Why CorMedix Inc.'s (NASDAQ:CRMD) CEO Compensation Is The Least Of Shareholders' Concerns - simplywall.st

Click here to get full coverage on CorMedix Inc. (CRMD): A Bull Case Theory - Yahoo Finance

CorMedix Inc. (CRMD): A Bull Case Theory  Yahoo Finance

CorMedix Inc. (CRMD): A Bull Case Theory - Yahoo Finance

Click here to get full coverage on RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term - Yahoo Finance

RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term  Yahoo Finance

RBC stays bullish on CorMedix as Q1 preliminary revenue reassures on near-term - Yahoo Finance

Click here to get full coverage on CorMedix Stock: Delayed Approval, Low Cash, Good Prospects (NASDAQ:CRMD) - Seeking Alpha

CorMedix Stock: Delayed Approval, Low Cash, Good Prospects (NASDAQ:CRMD)  Seeking Alpha

CorMedix Stock: Delayed Approval, Low Cash, Good Prospects (NASDAQ:CRMD) - Seeking Alpha

Click here to get full coverage on CorMedix stock rises after earnings, revenue beat - Seeking Alpha

CorMedix stock rises after earnings, revenue beat  Seeking Alpha

CorMedix stock rises after earnings, revenue beat - Seeking Alpha

Click here to get full coverage on CorMedix 2.0: New Leadership, New Approval, New Focus (NASDAQ:CRMD) - Seeking Alpha

CorMedix 2.0: New Leadership, New Approval, New Focus (NASDAQ:CRMD)  Seeking Alpha

CorMedix 2.0: New Leadership, New Approval, New Focus (NASDAQ:CRMD) - Seeking Alpha

Click here to get full coverage on CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is  GlobeNewswire

CORMEDIX ALERT: Bragar Eagel & Squire, P.C. is - GlobeNewswire

Click here to get full coverage on Cormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ... By GuruFocus - Investing.com Canada

Cormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ... By GuruFocus  Investing.com Canada

Cormedix Inc (CRMD) Q1 2025 Earnings Call Highlights: Record Profitability and Strategic Growth ... By GuruFocus - Investing.com Canada

Click here to get full coverage on CorMedix Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq

CorMedix Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025  Nasdaq

CorMedix Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025 - Nasdaq

Click here to get full coverage on While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate - simplywall.st

While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate  simplywall.st

While shareholders of CorMedix (NASDAQ:CRMD) are in the black over 1 year, those who bought a week ago aren't so fortunate - simplywall.st

Click here to get full coverage on CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 - The Globe and Mail

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025  The Globe and Mail

CorMedix Inc. to Report First Quarter 2025 Financial Results and Provide a Corporate Update on May 6, 2025 - The Globe and Mail

Click here to get full coverage on I’m (Finally) a Believer in This Low-Priced Biotech - TheStreet Pro

I’m (Finally) a Believer in This Low-Priced Biotech  TheStreet Pro

I’m (Finally) a Believer in This Low-Priced Biotech - TheStreet Pro

Click here to get full coverage on CorMedix shares tumble after order delay - Investing.com

CorMedix shares tumble after order delay  Investing.com

CorMedix shares tumble after order delay - Investing.com

Click here to get full coverage on Long Term Trading Analysis for (CRMD) - news.stocktradersdaily.com

Long Term Trading Analysis for (CRMD)  news.stocktradersdaily.com

Long Term Trading Analysis for (CRMD) - news.stocktradersdaily.com

Click here to get full coverage on CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call  Benzinga

CorMedix Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga

Click here to get full coverage on CorMedix Q4 Swings To Profit, Stock Down In Pre-market - Nasdaq

CorMedix Q4 Swings To Profit, Stock Down In Pre-market  Nasdaq

CorMedix Q4 Swings To Profit, Stock Down In Pre-market - Nasdaq

Click here to get full coverage on CorMedix Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

CorMedix Inc reports results for the quarter ended March 31 - Earnings Summary  TradingView

CorMedix Inc reports results for the quarter ended March 31 - Earnings Summary - TradingView

Click here to get full coverage on CorMedix (CRMD) Q4 2024 Earnings Call Transcript - AOL.com

CorMedix (CRMD) Q4 2024 Earnings Call Transcript  AOL.com

CorMedix (CRMD) Q4 2024 Earnings Call Transcript - AOL.com

Click here to get full coverage on CorMedix (CRMD) Boosts H1 Revenue Outlook Amid Strong Q1 Results - GuruFocus

CorMedix (CRMD) Boosts H1 Revenue Outlook Amid Strong Q1 Results  GuruFocus

CorMedix (CRMD) Boosts H1 Revenue Outlook Amid Strong Q1 Results - GuruFocus

Click here to get full coverage on CorMedix Logs Q1 Prel. Revenue Of $39 Mln - Nasdaq

CorMedix Logs Q1 Prel. Revenue Of $39 Mln  Nasdaq

CRMD

Price Chart

Key Statistics

Technicals

About CRMD

Latest News

Surging Earnings Estimates Signal Upside for CorMedix (CRMD) Stock - Nasdaq

Analysts Just Shipped A Substantial Upgrade To Their CorMedix Inc. (NASDAQ:CRMD) Estimates - Yahoo Finance

Breakeven Is Near for CorMedix Inc. (NASDAQ:CRMD) - simplywall.st

Advanced Charts

Top Gainers

Top Losers